ctDNA sequencing detects outcomes for pretreated advanced gastrointestinal stromal tumour

FOLFOXIRI plus panitumumab vs mFOLFOX6/PAN for unresectable RAS and BRAF wild-type mCC

Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Comment: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Trastuzumab deruxtecan doubles PFS in metastatic breast cancer with low HER2 expression

Comment: (RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients

Comment: Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients

Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients

Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients

(RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients

Avasopasem produces significant improvement of severe oral mucositis in head and neck patients

Everolimus after surgery can improve outcomes in those with high-risk kidney cancer